| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/2008 | CN100404046C Antiseptic for preventing and treating tinea unguium and tinea of feet and hands |
| 07/23/2008 | CN100404044C Chloasma diminishing medicine containing deer foetus and functional food and preparing method |
| 07/23/2008 | CN100404041C Medicinal composition for treating coronary heart disease |
| 07/23/2008 | CN100404040C Medicinal composition for treating cardiopathy and its preparation method and use |
| 07/23/2008 | CN100404039C Safflower medicine composition and its preparation process and use |
| 07/23/2008 | CN100404038C A health product of lucid ganoderma and preparation method thereof |
| 07/23/2008 | CN100404036C Ointment for treating piles |
| 07/23/2008 | CN100404035C Composition of Chinese traditional medicine for curing cardiovascular diseases and cerebrovascular disease |
| 07/23/2008 | CN100404034C An agent for controlling Bc1-2 expression comprising ginsenoside F1 as an active component |
| 07/23/2008 | CN100404033C Medicine composition for treating pulpitis |
| 07/23/2008 | CN100404032C Novel crystalline forms of the anti-cancer compound ZD1839 |
| 07/23/2008 | CN100404031C Soft capsule composition containing zine gluconate, Ibuprofen and chlorphenamine maleate |
| 07/23/2008 | CN100404030C Application of leflunomide in the preparation process of anti SARS virus medicine |
| 07/23/2008 | CN100404029C Use of geldanamycin ú¿C-3559ú®in preparing drug for herpesvirus genital tract affection |
| 07/23/2008 | CN100404028C Novel use of Brazil Hematine red |
| 07/23/2008 | CN100404027C Carbamaid peroxide freeze dried formulation for injection, its preparation method and uses |
| 07/23/2008 | CN100404026C Oral medicinal composition containing fudosteine |
| 07/23/2008 | CN100404025C Oral disintegrating tablet containing tramadol hydrochloride and acetaminopher, and its preparation method |
| 07/23/2008 | CN100404024C Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 07/23/2008 | CN100404023C Elemene soft capsule and its preparation process |
| 07/23/2008 | CN100404022C Adhesive composition for dermal patch and production process thereof |
| 07/23/2008 | CN100404021C Medical super fire micro capsule capsaicine and its preparing method |
| 07/23/2008 | CN100404019C Multivesicular emulsion topical delivery systems |
| 07/23/2008 | CN100403917C Method for the fractionation of oil and polar lipid-containing native raw material |
| 07/23/2008 | CN100403900C Mitotic kinesin inhibitors |
| 07/22/2008 | US7403805 Apparatus and method for noninvasive measurement of analytes from the conjunctiva using mid-infrared radiation |
| 07/22/2008 | US7403693 PVR set-up over the internet |
| 07/22/2008 | US7402725 WIP, a WASP-associated protein |
| 07/22/2008 | US7402706 Polyisoprenylated benzophenones and their isomers as inhibitors of histone acetyltransferases and uses thereof |
| 07/22/2008 | US7402704 Arylsulfones and uses related thereto |
| 07/22/2008 | US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402688 novel 2,2-disubstituted-19-norvitamin D derivatives and 20-epi-19-norvitamin D derivatives; metabolic regulatory hormone of calcium and phosphorus; biological activities: cellular induced differentiation, suppression of proliferation, and immunomodulation by transcription control of target gene |
| 07/22/2008 | US7402684 Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation |
| 07/22/2008 | US7402683 Cinnamic acid amides |
| 07/22/2008 | US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 07/22/2008 | US7402680 Nervous system disorders; psychological disorders; sleep disorders; anxiolytic agents; schizophrenia; analgesics; eating disorders |
| 07/22/2008 | US7402676 Substituted dihydro 3-halo-1H-pyrazole-5-carboxylates their preparation and use |
| 07/22/2008 | US7402674 antidiabetic agents; type 2 diabetes |
| 07/22/2008 | US7402673 Diamine β2 adrenergic receptor agonists |
| 07/22/2008 | US7402672 Central nervous system disorders; psychological disorders; sleep disorders |
| 07/22/2008 | US7402620 Lubricious coating |
| 07/22/2008 | US7402611 Use of amino acids for making medicines for treating to insulin-resistance |
| 07/22/2008 | US7402610 Carbonyl compound containing long-chain branched alkyl group |
| 07/22/2008 | US7402609 Olopatadine formulations for topical administration |
| 07/22/2008 | US7402608 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 07/22/2008 | US7402607 DNA-PK inhibitors |
| 07/22/2008 | US7402606 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402604 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., N-(2-hydroxy-1-phenylethyl) 4-hydroxy-1-methyl-1H-indole-2-carboxamide; nicotinic receptor agonist; conditions associated with reductions in nicotinic transmission; Alzheimer's disease, anxiety or schizophrenia |
| 07/22/2008 | US7402603 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 07/22/2008 | US7402602 Imidazole derivatives modulating the sodium channels |
| 07/22/2008 | US7402601 ADMINISTERING A DRUG CONTAINING N-(4-TRIFLUOROMETHYLphenyl)-5-METHYLISOXAZOLE-4-CARBOXANILIDE or N-(4-TRIFLUOROMETHYLPHENYL)-2-CYANO-3-HYDROXYCROTONAMIDE; antiinflammatory agents, immunomodulators, immunosuppressants |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402599 Protein structures and protein fibres |
| 07/22/2008 | US7402598 Arylethanolamine β2-adrenoreceptor agonist compounds |
| 07/22/2008 | US7402597 e.g. [[7-Allyl-3-[2-[2-(2,4-dichlorophenyl)-5-isopropyl-4-oxazolyl]ethyl]-1,2-benzisoxazol-6-yl]oxy]acetic acid; with vehicles (lactose, D-mannitol, glucose), disintegrators (starch or carboxymethylcellulose calcium ), binders (hydroxypropylcellulose) and lubricants (magnesium stearate or talc) |
| 07/22/2008 | US7402596 e.g. 2-Adamantan-1-yl-N-(2-isobutyl-1-oxo-1,2-dihydro-isoquinolin-5-yl)-ace tamide; antiinflammatory and analgesic agent; rheumatoid arthritis, osteoarthritis, Parkinson's disease, uveitis, asthma, cardiovascular conditions, myocardial infarction |
| 07/22/2008 | US7402595 JNK inhibitor |
| 07/22/2008 | US7402594 isoquinoline ring joined to a phenyl ring by a chemical group that is two bonds long and at least one cation or cationic group selected from sodium, potassium, ammonium, and tetraalkylammonium; Factor Xa inhibitor; anticoagulant; straightforward and economical synthesis |
| 07/22/2008 | US7402593 (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazo[4,5-b]pyridine; proton pump inhibitor (PPI) to treat gastro-oesophageal reflux, digestive bleeding and dyspepsia; enantiomer; long duration of action; longer half-life in plasma; oxidation of sulfide followed by salt formation |
| 07/22/2008 | US7402592 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
| 07/22/2008 | US7402591 Analgesic compositions containing buprenorphine |
| 07/22/2008 | US7402590 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/22/2008 | US7402589 such as 1-(4-Fluorophenyl)-1-{2-[(1S)-2-hydroxy-1,2-dimethyl-propylamino]-pyrimidin-4-yl}-3-o-tolyl-urea; Interleukin-1, Cycloxygenase-2, Tumor Necrosis Factor- alpha antagonist; antiinflammatory agent; rheumatoid arthritis or osteoarthritis |
| 07/22/2008 | US7402588 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/22/2008 | US7402587 Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists |
| 07/22/2008 | US7402586 3-Benzylsulfonylamino-6-methyl-1-[(3-guanidinooxypropyl)aminocarbonylmethyl]-2-pyridinone trifluoroacetate; anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 07/22/2008 | US7402585 For example, 2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-phenylacetamide; use in the treatment of certain diseases, in particular to proliferative disease such as cancer |
| 07/22/2008 | US7402583 Substituted quinolines as antitumor agents |
| 07/22/2008 | US7402582 such as 2-(2-{[6-({3-[4-(hydroxymethyl)piperidin-1-yl]propyl}oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino}-1,3-thiazol-5-yl)-N-(3-methylphenyl)acetamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent; |
| 07/22/2008 | US7402581 3,5-Dibromo-N-[(2S)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-N-methylbenzamide; neurokinin 1 and 2 (NK1,2) receptors, antagonist; improved pharmacokinetics: not inhibit liver enzyme cytochrome P450, prevent drug-drug interactions, oral bioavailability, antiinflammatory and analgesic |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402579 Quinobenzoxazine analogs and compositions |
| 07/22/2008 | US7402578 Methods for inhibiting cognitive deterioration in adults with down's syndrome |
| 07/22/2008 | US7402577 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/22/2008 | US7402576 Phosphinic acid analogs of glutamate |
| 07/22/2008 | US7402575 Methods of treating inflammation |
| 07/22/2008 | US7402574 Antisense composition and method for treating cancer |
| 07/22/2008 | US7402573 Use of nanoparticles for the DNA administration to a target organ |
| 07/22/2008 | US7402572 Suppressing a symptom of an allergic response using nucleic acids containing unmethylated CpG dinucleotides |
| 07/22/2008 | US7402571 Methods and pharmaceutical compositions for healing wounds |
| 07/22/2008 | US7402570 kits for detecting amplification or elevated expression for diagnosis; genetic engineering; solid phase synthesis |
| 07/22/2008 | US7402569 Combining such as sulforaphane with glucosinolate component; economical food additive or dietary supplement |
| 07/22/2008 | US7402568 Bicyclic 9a-azalide derivatives |
| 07/22/2008 | US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine) |
| 07/22/2008 | US7402430 Preparing synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders |
| 07/22/2008 | US7402429 Stably transfected plasmids that express polymerase, viral proteins from measles or mumps; Paramyxoviridae; use in vaccines or gene therapy |
| 07/22/2008 | US7402421 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/22/2008 | US7402414 Enzymatic process for deacetylation of a phenoxy-alkynyl acetate to the corresponding alcohol |
| 07/22/2008 | US7402406 Methods of evaluating phosphatase inhibitors |
| 07/22/2008 | US7402405 Obtaining sample of blood from mammal; administering digestible first fatty acid- containing substrate; obtaining sample; assaying; determining from the rate of fatty acid absorption of fatty acid-substrate; comparing |
| 07/22/2008 | US7402399 Determination activation; measurement dimerization; detection, therapy of cancer |
| 07/22/2008 | US7402388 Using immunophilin (FKBP54) expression as diagnostic/prognostic indicator of cell proliferative disorders; antitumor agents |
| 07/22/2008 | US7402321 Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles |
| 07/22/2008 | US7402318 Medical devices having antimicrobial coatings thereon |
| 07/22/2008 | US7402313 Calculating a suitable dosage of digoxin immune fab, administering by intravenous bolus and repeating |
| 07/22/2008 | US7402311 Composition and method for treating non-bacterial cystitis |
| 07/22/2008 | US7402309 Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions |
| 07/22/2008 | US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |